Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;194(4):788-792.
doi: 10.1111/bjh.17551. Epub 2021 May 26.

Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies

Affiliations

Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies

Aurélien Corneau et al. Br J Haematol. 2021 Aug.
No abstract available

Keywords: chimaeric antigen receptor-T cells; immunomonitoring; mass cytometry.

PubMed Disclaimer

References

    1. June CH, Sadelain M. Chimeric antigen receptor therapy. N Engl J Med. 2018;379:64-73.
    1. Mueller KT, Maude SL, Porter DL, Frey N, Wood P, Han X, et al. Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood. 2017;130:2317-25.
    1. Shah NN, Fry T. Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol. 2019;16:372-85.
    1. Fraietta JA, Lacey SF, Orlando EJ, Pruteanu-Malinici I, Gohil M, Lundh S, et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med. 2018;24:563-71.
    1. Du M, Hari P, Hu Y, Mei H. Biomarkers in individualized management of chimeric antigen receptor T cell therapy. Biomarker. 2020;8:1-13.

Publication types

MeSH terms

LinkOut - more resources